Cargando…

Reduced Glycemic Variability in Diazoxide-Responsive Children with Congenital Hyperinsulinism Using Supplemental Omega-3-Polyunsaturated Fatty Acids; A Pilot Trial with MaxEPA(R)

Objective: Congenital hyperinsulinism (CHI) is a rare condition of hypoglycemia where therapeutic options are limited and often complicated by side-effects. Omega-3-polyunsaturated fatty acids (PUFA), which can suppress cardiac myocyte electrical activity, may also reduce ion channel activity in ins...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skae, Mars, Avatapalle, Hima Bindu, Banerjee, Indraneel, Rigby, Lindsey, Vail, Andy, Foster, Peter, Charalambous, Christiana, Bowden, Louise, Padidela, Raja, Patel, Leena, Ehtisham, Sarah, Cosgrove, Karen E., Dunne, Mark J., Clayton, Peter E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952031/ https://www.ncbi.nlm.nih.gov/pubmed/24659984 http://dx.doi.org/10.3389/fendo.2014.00031

Ejemplares similares

Feeding Problems Are Persistent in Children with Severe Congenital Hyperinsulinism
por: Banerjee, Indraneel, et al.
Publicado: (2016)

Abnormal Neurodevelopmental Outcomes are Common in Children with Transient Congenital Hyperinsulinism
por: Avatapalle, Hima Bindu, et al.
Publicado: (2013)

Can network biology unravel the aetiology of congenital hyperinsulinism?
por: Stevens, Adam, et al.
Publicado: (2013)

Vineland adaptive behavior scales to identify neurodevelopmental problems in children with Congenital Hyperinsulinism (CHI)
por: Salomon-Estebanez, Maria, et al.
Publicado: (2017)

Conservatively treated Congenital Hyperinsulinism (CHI) due to K-ATP channel gene mutations: reducing severity over time
por: Salomon-Estebanez, Maria, et al.
Publicado: (2016)

Enhanced Islet Cell Nucleomegaly Defines Diffuse Congenital Hyperinsulinism in Infancy but Not Other Forms of the Disease
por: Han, Bing, et al.
Publicado: (2016)

Central venous catheter-associated thrombosis in children with congenital hyperinsulinism
por: Yau, Daphne, et al.
Publicado: (2019)

Dietary fish oil (MaxEPA) enhances pancreatic carcinogenesis in azaserine-treated rats.
por: Appel, M. J., et al.
Publicado: (1996)

Atypical Forms of Congenital Hyperinsulinism in Infancy Are Associated With Mosaic Patterns of Immature Islet Cells
por: Han, Bing, et al.
Publicado: (2017)

Diazoxide-Induced Hypertrichosis in a Neonate With Transient Hyperinsulinism
por: Boskabadi, Seyyed Javad, et al.
Publicado: (2023)

Clinical Diversity in Focal Congenital Hyperinsulinism in Infancy Correlates With Histological Heterogeneity of Islet Cell Lesions
por: Craigie, Ross J., et al.
Publicado: (2018)

Diazoxide-unresponsive congenital hyperinsulinism associated with ABCC8 nonsense mutation
por: Hussain, Suhaimi, et al.
Publicado: (2015)

Efficacy and safety of octreotide treatment for diazoxide‐unresponsive congenital hyperinsulinism in China
por: Cao, Bingyan, et al.
Publicado: (2020)

Genotype-phenotype correlation in Taiwanese children with diazoxide-unresponsive congenital hyperinsulinism
por: Lee, Cheng-Ting, et al.
Publicado: (2023)

Partial diazoxide responsiveness in a neonate with hyperinsulinism due to homozygous ABCC8 mutation
por: Kiff, Sarah, et al.
Publicado: (2019)

SUN-690 HNF4A Mutation in Siblings with Diazoxide Responsive Congenital Hyperinsulinism
por: Erkin-Cakmak, Ayca, et al.
Publicado: (2020)

A novel mutation of ABCC8 gene in a patient with diazoxide-unresponsive congenital hyperinsulinism
por: Park, Ji Sook, et al.
Publicado: (2016)

In Vitro Recovery of ATP-Sensitive Potassium Channels in β-Cells From Patients With Congenital Hyperinsulinism of Infancy
por: Powell, Philippa D., et al.
Publicado: (2011)

Diazoxide-Unresponsive Congenital Hyperinsulinism in Children With Dominant Mutations of the β-Cell Sulfonylurea Receptor SUR1
por: MacMullen, Courtney M., et al.
Publicado: (2011)

Congenital hyperinsulinism: clinical and molecular characterisation of compound heterozygous ABCC8 mutation responsive to Diazoxide therapy
por: Arya, Ved Bhushan, et al.
Publicado: (2014)

MON-105 A Case Report of Neonatal Hyperinsulinism in an Infant with Turner Syndrome Successfully Treated with Diazoxide
por: Patterson, Rebecca J, et al.
Publicado: (2020)

SUN-273 Diazoxide Use to Limit Weight Gain and Reduce Appetite in a Normoglycaemic Child with Previous Congenital Hyperinsulinism
por: Ludwig, Karissa, et al.
Publicado: (2019)

Neonatal Hypo-Ketotic Hypoglycemia Secondary to Transient Hyperinsulinism: Diazoxide Responsiveness and Experience With Fasting Test After Treatment Withdrawal
por: Martín, Nerea Itza, et al.
Publicado: (2021)

Birth weight and diazoxide unresponsiveness strongly predict the likelihood of congenital hyperinsulinism due to a mutation in ABCC8 or KCNJ11
por: Hewat, Thomas I., et al.
Publicado: (2021)

Novel Compound Heterozygous Variants of the ABCC8 Gene Warrant Identification of Pancreatic Histology in Infant with Diazoxide-unresponsive Congenital Hyperinsulinism
por: Al Balwi, Rana, et al.
Publicado: (2021)

PSUN340 Two cases of diffuse form of diazoxide-responsive congenital hyperinsulinism confirmed by 18F-DOPA PET-CT
por: Yu, Jeesuk, et al.
Publicado: (2022)

Insight into hypoglycemia frequency in congenital hyperinsulinism: evaluation of a large UK CGM dataset
por: Worth, Chris, et al.
Publicado: (2022)

Endocrinopathies in Aicardi Goutières syndrome—A descriptive case series
por: Worth, Chris, et al.
Publicado: (2020)

Adjacent mutations in the gating loop of Kir6.2 produce neonatal diabetes and hyperinsulinism
por: Shimomura, Kenju, et al.
Publicado: (2009)

Extreme caution on the use of sirolimus for the congenital hyperinsulinism in infancy patient
por: Banerjee, Indraneel, et al.
Publicado: (2017)

SAT-271 Higher C-Peptide Levels and Glucose Requirements May Identify Neonates with Transient Hyperinsulinism Hypoglycemia Who Will Benefit from Diazoxide Treatment
por: Schachter Davidov, Anita, et al.
Publicado: (2019)

Increased proliferation and altered cell cycle regulation in pancreatic stem cells derived from patients with congenital hyperinsulinism
por: Kellaway, Sophie G., et al.
Publicado: (2019)

Standardised practices in the networked management of congenital hyperinsulinism: a UK national collaborative consensus
por: Shaikh, M. Guftar, et al.
Publicado: (2023)

Correction: Increased proliferation and altered cell cycle regulation in pancreatic stem cells derived from patients with congenital hyperinsulinism
por: Kellaway, Sophie G., et al.
Publicado: (2019)

Delayed Resolution of Feeding Problems in Patients With Congenital Hyperinsulinism
por: Worth, Chris, et al.
Publicado: (2020)

The burden of congenital hyperinsulinism in the United Kingdom: a cost of illness study
por: Eljamel, Sana, et al.
Publicado: (2018)

Therapies and outcomes of congenital hyperinsulinism‐induced hypoglycaemia
por: Banerjee, I., et al.
Publicado: (2018)

Hyperinsulinism
Publicado: (1932)

Successful medical management of insulinoma with diazoxide for 27 years
por: Warren, Annabelle M, et al.
Publicado: (2020)

Unravelling the genetic causes of mosaic islet morphology in congenital hyperinsulinism
por: Houghton, Jayne AL, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4koi2rmpe8j98fjrcbmmm0ht57